Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Seven pharma companies offer up compounds to UK researchers
-
AstraZeneca reveals designs for new Global R&D Centre and Corporate Headquarters in Cambridge, UK
-
AstraZeneca and Max Planck Institute announce research agreement to create satellite chemistry unit for cardiovascular and metabolic diseases
-
MRC Technology and AstraZeneca Renew Collaboration to Identify Novel Targets for Discovery Research
-
FDA Advisory Committee votes on accelerated approval for investigational medicine olaparib
-
ADDC and AstraZeneca partner to foster novel drug development among academic research community
-
US FDA Advisory Committee recommends no cardiovascular outcomes trial for peripherally-acting mu-opioid receptor antagonist (PAMORA) class including MOVANTIK
-
AstraZeneca in-licenses Synairgen's SNG001 as a novel immuno-modulatory therapy for viral-induced exacerbation in asthma
-
Brodalumab treatment improved clinical signs and symptoms in Phase II psoriatic arthritis study published in the New England Journal of Medicine
-
AstraZeneca to present new data from its broad portfolio in wide range of patient populations at the American Diabetes Association 74th Scientific Sessions®
Latest articles and press releases
All of our latest press releases and articles are available to explore
